Norway has a population of approximately 5 million people. As well as being involved in a number of major Initiatives around personalised medicine, Norway has a national strategy for personalised medicine within the health service. The strategy will contribute to development and implementation in the health service in the period 2017-2021.
In collaboration with regional health authorities, the Research Council also published an action plan for research and innovation in personalised medicine. The action plan proposes a number of measures to achieve: Increased interaction, international cooperation, leverage national advantages, increased visibility, more interdisciplinarity and better coordination, reduced barriers to interaction, responsible research and innovation.
Strategi for persontilpasset medisin i helsetjenesten
Handlingsplan for forskning og innovasjon innenfor persontilpasset medisin (2018–2021)
Dette er persontilpasset medisin
Nordic NOK 165 million initiative to boost research and innovation in personalised medicine
ERA PerMed AML_PM
Horizon 2020 AMLvaccin
University of Bergen biobank/genome sequencing infrastructure/super computer/strategic research centra
Haukeland University Hospital, Helse Bergen HF biobank/genome sequencing infrastructure/super computer/strategic research centra
NorCRIN Trial infrastructure
Is the region represented in: Horizon2020; Regional Smart Specialisation Strategy Platforms/Partnerships (RIS3); EIT Health/InnoStars/Regional Innovation Scheme (RIS); other?
If you would like to add your region to the Observatory please complete the survey here
By Rob984 - Derived from File:Germany on the globe (Germany centered).svg, CC BY-SA 4.0,